Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 0.21% for the current model date.
BlackTreeCVE IntelligenceRed Hat · Red Hat Ansible Automation Platform 2.5 for RHEL 8
Official source article: Red Hat RHSA-2026:71113 ↗. Check the applicable product and release in the original source.
Low technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Structured product status and remediation from the issuing vendor. Product-state explanations are always visible; large lists can be searched or downloaded.
The vendor explicitly identifies these products or versions as containing the fix.
Low technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Patch availableLaunchConfigurationBaseSerializer.scm_branch has no validate_scm_branch() leading-dash check, unlike Project/JobTemplate/JobLaunch serializers. Schedule and WFJT Node accept --upload-pack=/bin/id as scm_branch. Currently blocked at runtime by jobs.py:1502 ValueError check (defense-in-depth), but the API validation gap means sole reliance on a task-layer guard. Refactoring that guard away would promote this to RCE.
LaunchConfigurationBaseSerializer.scm_branch has no validate_scm_branch() leading-dash check, unlike Project/JobTemplate/JobLaunch serializers. Schedule and WFJT Node accept --upload-pack=/bin/id as scm_branch. Currently blocked at runtime by jobs.py:1502 ValueError check (defense-in-depth), but the API validation gap means sole reliance on a task-layer guard. Refactoring that guard away would promote this to RCE.
The product constructs a string for a command to be executed by a separate component in another control sphere, but it does not properly delimit the intended arguments, options, or switches within that command string.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
LaunchConfigurationBaseSerializer.scm_branch has no validate_scm_branch() leading-dash check, unlike Project/JobTemplate/JobLaunch serializers. Schedule and WFJT Node accept --upload-pack=/bin/id as scm_branch. Currently blocked at runtime by jobs.py:1502 ValueError check (defense-in-depth), but the API validation gap means sole reliance on a task-layer guard. Refactoring that guard away would promote this to RCE.
The product constructs a string for a command to be executed by a separate component in another control sphere, but it does not properly delimit the intended arguments, options, or switches within that command string.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-88: Improper Neutralization of Argument Delimiters in a Command ('Argument Injection'). The product constructs a string for a command to be executed by a separate component in another control sphere, but it does not properly delimit the intended arguments, options, or switches within that command string.
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:N/I:L/A:NCommon Vulnerability Scoring System 3.1: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 23 Sept 2026 · Last source change 24 Sept 2026, 06:14 UTC · CWE-88 · Improper Neutralization of Argument Delimiters in a Command ('Argument Injection')
Missing structured fields: affected versions. Missing data is not evidence of low risk; review the primary advisory.